Viveve Medical, Inc.
VIVE
$0.0002
$0.000.00%
OTC PK
09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
---|---|---|---|---|---|
Net Income | -22.99M | -23.87M | -22.12M | -22.03M | -20.45M |
Total Depreciation and Amortization | 808.00K | 878.00K | 1.02M | 1.14M | 1.23M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 5.18M | 5.45M | 3.75M | 3.89M | 3.53M |
Change in Net Operating Assets | 767.00K | 2.00M | 2.65M | 4.12M | 3.75M |
Cash from Operations | -16.23M | -15.55M | -14.71M | -12.88M | -11.95M |
Capital Expenditure | -595.00K | -486.00K | -420.00K | -456.00K | -540.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -595.00K | -486.00K | -420.00K | -456.00K | -540.00K |
Total Debt Issued | -- | -- | -- | -- | 0.00 |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 68.00K | 70.00K | 761.00K | 26.04M | 26.03M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 1.00K | 1.00K | -30.00K | -70.00K | -72.00K |
Cash from Financing | 69.00K | 71.00K | 731.00K | 25.97M | 25.95M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -16.76M | -15.96M | -14.40M | 12.64M | 13.47M |